KYNB
KYNB
NASDAQ · Biotechnology

Kyntra Bio Inc

$7.00
+0.22 (+3.24%)
As of Apr 1, 3:51 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +355.9% upside
Low Target $24.67
Average Target $31.91
High Target $44.05
Current Price $7.00
Current
$7.00
Target
$31.91
$24.67 $31.91 avg $44.05
Scenario Analysis
Bear Case
$24.67
252.4%
Low target
Base Case
$31.91
+355.9%
Avg target
Bull Case
$44.05
+529.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.60
-44.4% from high
52-Week Low
$4.85
+44.3% from low
Target vs 52W High
$31.91
+153.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%